This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on ISI (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Skin Cancer  • Dermatology  • Melanoma  • Surgical Oncology  • Prognosis/ Outcomes  • Alert me on articles by topic  Social Bookmarking   What's this?

C. K. Chang, MD; Ira A. Jacobs, MD; Vida M. Vizgirda, RN, PhD; George I. Salti, MD

Arch Surg. 2003;138:1135-1138.

Background  The incidence of cutaneous melanoma is rising steadily, and the rate of increase is among the highest for any form of cancer. Although the reliability of age as a prognostic factor is debatable, several studies suggest that age has an important prognostic use.

Hypothesis  Age alone does not predict a poor prognosis in the older patient with melanoma.

Setting  University teaching hospital.

Methods  A retrospective review was undertaken to identify patients aged 65 years or older with intermediate-thickness melanoma (1-4 mm). Two hundred thirteen such patients were identified. Data are given as mean ± SD.

Results  The mean age was 72.2 ± 6.1 years. The mean follow-up was 49 months. By univariate analysis, the mean disease-free survival (DFS) and overall survival (OS) for lymph node–positive patients was 36.0 ± 9.6 and 56.0 ± 10.6 months, respectively. The mean DFS for node-negative patients was 155.0 ± 9.8 months, and the mean OS was 166.0 ± 9.2 months (P<.001 for both). The mean DFS and OS for women were 151.0 ± 11.2 and 163.0 ± 10.9 months, respectively. In contrast, men had 116.0 ± 9.5 months' DFS and 127.0 ± 9.0 months' OS (P = .01 for both). By multivariate analysis, lymph node status was the most predictive variable for DFS and OS (P<.001 for both). Sex tended to affect OS (P = .02) but did not achieve prognostic significance on DFS (P = .09). Other factors such as location, ulceration, histological type, and mitoses per square millimeter failed to show any prognostic significance. Stratification into 3 age groups (65-70, 71-80, and >80 years) had no significant effect on DFS (P = .95) or OS (P = .92).

Conclusions  Lymph node status is the most important prognostic factor in older patients with intermediate-thickness melanoma. Identification of high-risk factors may help stratify these patients for recommendation of more aggressive treatment or adjuvant therapies. Among these patients, age alone was not a significant prognostic factor in the clinical management of melanoma.

From the Department of Surgical Oncology, University of Illinois at Chicago. Dr Chang is now with the Department of Surgical Oncology, Naples Community Hospital, Naples, Fla.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?